BindingDB logo
myBDB logout

BDBM272555 US10065967, Example 21::US9745307, Example 21

SMILES: Cc1cccc(CN2Cc3cc4c(n[nH]c4cc3NC2=O)-c2ccnc(C)c2)n1

InChI Key: InChIKey=OUOZZVSWSXPESX-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 272555   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM272555
PNG
(US10065967, Example 21 | US9745307, Example 21)
Show SMILES Cc1cccc(CN2Cc3cc4c(n[nH]c4cc3NC2=O)-c2ccnc(C)c2)n1
Show InChI InChI=1S/C22H20N6O/c1-13-4-3-5-17(24-13)12-28-11-16-9-18-20(10-19(16)25-22(28)29)26-27-21(18)15-6-7-23-14(2)8-15/h3-10H,11-12H2,1-2H3,(H,25,29)(H,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 0.600n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9745307 (2017)


Article DOI: 10.1016/j.bmc.2006.03.042
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM272555
PNG
(US10065967, Example 21 | US9745307, Example 21)
Show SMILES Cc1cccc(CN2Cc3cc4c(n[nH]c4cc3NC2=O)-c2ccnc(C)c2)n1
Show InChI InChI=1S/C22H20N6O/c1-13-4-3-5-17(24-13)12-28-11-16-9-18-20(10-19(16)25-22(28)29)26-27-21(18)15-6-7-23-14(2)8-15/h3-10H,11-12H2,1-2H3,(H,25,29)(H,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 0.600n/an/an/an/an/an/a



Merck, Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US10065967 (2018)


Article DOI: 10.1021/jm9802259
More data for this
Ligand-Target Pair